Lia Gutiérrez

454 total citations
22 papers, 351 citations indexed

About

Lia Gutiérrez is a scholar working on Surgery, Dermatology and Epidemiology. According to data from OpenAlex, Lia Gutiérrez has authored 22 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Dermatology and 5 papers in Epidemiology. Recurrent topics in Lia Gutiérrez's work include BRCA gene mutations in cancer (3 papers), Migraine and Headache Studies (3 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Lia Gutiérrez is often cited by papers focused on BRCA gene mutations in cancer (3 papers), Migraine and Headache Studies (3 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Lia Gutiérrez collaborates with scholars based in United States, Denmark and Sweden. Lia Gutiérrez's co-authors include Jordi Castellsagué, Anders Mattsson, Maria Kołtowska‐Häggström, Anton Luger, Peter Jönsson, James A. Kaye, B Westberg, Susana Perez‐Gutthann, Kenneth J. Rothman and Jesper Hallas and has published in prestigious journals such as American Journal of Epidemiology, Bone and Breast Cancer Research and Treatment.

In The Last Decade

Lia Gutiérrez

22 papers receiving 337 citations

Peers

Lia Gutiérrez
Sang Pyo Kim South Korea
T. Lotti Italy
Irene Weiss United States
Matthew Chapman Australia
Bensen Wg Canada
Thomas D. Wooldridge United Kingdom
Lia Gutiérrez
Citations per year, relative to Lia Gutiérrez Lia Gutiérrez (= 1×) peers Eleni Efremidou

Countries citing papers authored by Lia Gutiérrez

Since Specialization
Citations

This map shows the geographic impact of Lia Gutiérrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lia Gutiérrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lia Gutiérrez more than expected).

Fields of papers citing papers by Lia Gutiérrez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lia Gutiérrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lia Gutiérrez. The network helps show where Lia Gutiérrez may publish in the future.

Co-authorship network of co-authors of Lia Gutiérrez

This figure shows the co-authorship network connecting the top 25 collaborators of Lia Gutiérrez. A scholar is included among the top collaborators of Lia Gutiérrez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lia Gutiérrez. Lia Gutiérrez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aguado, Jaume, et al.. (2024). Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: a target trial emulation study. American Journal of Epidemiology. 194(3). 691–698. 1 indexed citations
3.
Stenehjem, David D., Sudhir Unni, Hillevi Bauer, et al.. (2021). BRCA testing and outcomes in women with breast cancer. Breast Cancer Research and Treatment. 186(3). 839–850. 8 indexed citations
4.
Kulschewski, Anke, et al.. (2021). Validity of hospital ICD‐10‐GM codes to identify anaphylaxis. Pharmacoepidemiology and Drug Safety. 30(12). 1643–1652. 2 indexed citations
6.
Kuiper, Josephina G., Myrthe P. P. van Herk‐Sukel, Jordi Castellsagué, et al.. (2018). Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study. Drugs - Real World Outcomes. 5(2). 109–116. 1 indexed citations
7.
Castellsagué, Jordi, Josephina G. Kuiper, Anton Pottegård, et al.. (2018). A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study). Clinical Epidemiology. Volume 10. 299–310. 79 indexed citations
8.
Haque, Reina, Jiaxiao Shi, Chantal Avila, et al.. (2018). Survival Outcomes in BRCA1 or BRCA2 Mutation Carriers and the Influence of Triple-Negative Breast Cancer Subtype. The Permanente Journal. 22(4). 7 indexed citations
9.
Cronin‐Fenton, Deirdre, Anders Kjærsgaard, Mette Nørgaard, et al.. (2017). Clinical outcomes of female breast cancer according to BRCA mutation status. Cancer Epidemiology. 49. 128–137. 9 indexed citations
10.
Matharu, Manjit, Julio Pascual, Ingela Nilsson Remahl, et al.. (2017). Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe. Cephalalgia. 37(14). 1384–1397. 35 indexed citations
11.
Kuiper, JG, Jordi Castellsagué, Anton Pottegård, et al.. (2016). Utilization of Topical Tacrolimus and Topical Pimecrolimus in Europe: Results From The Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (Joelle) Study. Value in Health. 19(7). A573–A573. 1 indexed citations
12.
Matharu, Manjit, Julio Pascual, Catherine B. Johannes, et al.. (2015). Interim analysis of the real-world utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine in an observational study in the European Union. UCL Discovery (University College London). 1 indexed citations
13.
Gutiérrez, Lia, Neil Roskell, Jordi Castellsagué, et al.. (2012). Clinical burden and incremental cost of fractures in postmenopausal women in the United Kingdom. Bone. 51(3). 324–331. 22 indexed citations
14.
Gutiérrez, Lia, Neil Roskell, Jordi Castellsagué, et al.. (2011). Study of the incremental cost and clinical burden of hip fractures in postmenopausal women in the United Kingdom. Journal of Medical Economics. 14(1). 99–107. 33 indexed citations
15.
Huang, Kui, Lia Gutiérrez, Steffen Bülow, et al.. (2011). Clinical characteristics and outcomes in familial adenomatous polyposis patients with a long-term treatment of celecoxib: a matched cohort study. Familial Cancer. 10(2). 303–308. 14 indexed citations
16.
Gutiérrez, Lia, Maria Kołtowska‐Häggström, Peter Jönsson, et al.. (2007). Registries as a tool in evidence‐based medicine: example of KIMS (Pfizer International Metabolic Database). Pharmacoepidemiology and Drug Safety. 17(1). 90–102. 57 indexed citations
17.
Arana, Alejandro, Cristina Varas, Antonio González‐Pérez, et al.. (2006). Hormone therapy and cerebrovascular events. Menopause The Journal of The North American Menopause Society. 13(5). 730–736. 32 indexed citations
18.
Gutiérrez, Lia, et al.. (2003). La información escrita del farmacéutico mejora el cumplimiento de la antibioterapia The effect of written information provided by pharmacists on compliance with antibiotherapy. 3 indexed citations
19.
Dhingra, Kapil, Daniel J. Booser, Aman U. Buzdar, et al.. (1994). Suppression of Human Anti-Mouse Antibody Response to Murine Monoclonal Antibody L6 by Deoxyspergualin: A Phase I Study. Advances in experimental medicine and biology. 353. 193–202. 5 indexed citations
20.
Dhingra, Kapil, Vicente Valero, Lia Gutiérrez, et al.. (1994). Phase II study of deoxyspergualin in metastatic breast cancer. Investigational New Drugs. 12(3). 235–241. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026